CAR T Cell Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
91
NCT04836507
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients
Phase: Phase 1/2
Role: Lead Sponsor
Start: Mar 2, 2021
Completion: Feb 29, 2028
Loading map...